460
Participants
Start Date
October 16, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
December 31, 2027
RMC-6236
Oral Tablets
Gemcitabine
intravenous (IV) infusion
nab-paclitaxel
IV infusion
Irinotecan
IV infusion
Liposomal irinotecan
IV infusion
5-fluorouracil
IV infusion
leucovorin
IV infusion
Oxaliplatin
IV infusion
ACTIVE_NOT_RECRUITING
NYU Lagone Health, New York
ACTIVE_NOT_RECRUITING
Memorial Sloan Kettering Cancer Center, New York
ACTIVE_NOT_RECRUITING
Columbia University Medical Center, New York
ACTIVE_NOT_RECRUITING
Institut Paoli Calmettes, Marseille
RECRUITING
Charité Universitätsmedizin, Campus Berlin Mitte, Berlin
ACTIVE_NOT_RECRUITING
Roswell Park Cancer Institute, Buffalo
ACTIVE_NOT_RECRUITING
UPMC Hillman Cancer Center, Pittsburgh
ACTIVE_NOT_RECRUITING
Abramson Cancer Center Clinical Research Unit, Philadelphia
ACTIVE_NOT_RECRUITING
Johns Hopkins, Baltimore
ACTIVE_NOT_RECRUITING
Virginia Cancer Specialists, Fairfax
ACTIVE_NOT_RECRUITING
Duke University Medical Center, Durham
ACTIVE_NOT_RECRUITING
Hospital 12 de Octubre, Madrid
ACTIVE_NOT_RECRUITING
Clinica Universidad de Navarra, Pamplona
ACTIVE_NOT_RECRUITING
Mayo Clinic Cancer Center - Florida, Jacksonville
ACTIVE_NOT_RECRUITING
Cancer Care Centers of Brevard Inc, Palm Bay
ACTIVE_NOT_RECRUITING
University of Miami Sylvester Comprehensive Cancer Center, Miami
ACTIVE_NOT_RECRUITING
Moffitt Cancer Center, Tampa
ACTIVE_NOT_RECRUITING
Centre Eugene Marquis, Rennes
ACTIVE_NOT_RECRUITING
IOV-Istituto Oncologico, Padua
ACTIVE_NOT_RECRUITING
Sarah Cannon Research Institute (Tennessee), Nashville
ACTIVE_NOT_RECRUITING
University of Cincinnati Medical Center, Cincinnati
ACTIVE_NOT_RECRUITING
Hospital Clinico de Valencia, Valencia
ACTIVE_NOT_RECRUITING
University of Michigan, Ann Arbor
ACTIVE_NOT_RECRUITING
Karmanos Cancer Institute, Detroit
ACTIVE_NOT_RECRUITING
Mayo Clinic Cancer Center - Rochester, Rochester
ACTIVE_NOT_RECRUITING
Azienda Ospedaliera, Pisa
ACTIVE_NOT_RECRUITING
The University of Chicago Medical Center, Chicago
ACTIVE_NOT_RECRUITING
Washington University, St Louis
RECRUITING
Nationales Centrum fur, Heidelberg
ACTIVE_NOT_RECRUITING
Stephenson Cancer Center, Oklahoma City
ACTIVE_NOT_RECRUITING
Texas Oncology - Central South, Irving
ACTIVE_NOT_RECRUITING
Texas Oncology Sammons, Dallas
ACTIVE_NOT_RECRUITING
MD Anderson Cancer Center, Houston
ACTIVE_NOT_RECRUITING
Rocky Mountain Cancer, Aurora
RECRUITING
Universitatsklinikum Ulm, Zentru, München
ACTIVE_NOT_RECRUITING
Huntsman Cancer Institute, Salt Lake City
ACTIVE_NOT_RECRUITING
Mayo Clinic Cancer Center - Phoenix, Phoenix
ACTIVE_NOT_RECRUITING
Banner MD Anderson Cancer Center, Gilbert
RECRUITING
Universitatsklinikum Ulm, Ulm
ACTIVE_NOT_RECRUITING
Cedars-Sinai Medical Center, Los Angeles
ACTIVE_NOT_RECRUITING
UCLA, Los Angeles
ACTIVE_NOT_RECRUITING
City of Hope-Duarte, Duarte
ACTIVE_NOT_RECRUITING
UC San Diego Health Moores Cancer Center, San Diego
ACTIVE_NOT_RECRUITING
Mission Hall UCSF, San Francisco
ACTIVE_NOT_RECRUITING
Hopital Paul Brousse, Villejuif
ACTIVE_NOT_RECRUITING
Gustave Roussy, Villejuif
ACTIVE_NOT_RECRUITING
The Queen's Medical Center, Honolulu
ACTIVE_NOT_RECRUITING
Oregon Health and Science University, Portland
ACTIVE_NOT_RECRUITING
Fred Hutchinson Cancer Center, Seattle
RECRUITING
Aichi Cancer Center, Nagoya
ACTIVE_NOT_RECRUITING
Dana Farber Cancer Institute, Boston
ACTIVE_NOT_RECRUITING
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
ACTIVE_NOT_RECRUITING
IEO-Istituto Europeo di Oncologia, Milan
RECRUITING
National Cancer Center, Chiba
RECRUITING
Osaka International Cancer, Osaka
RECRUITING
National Cancer Center Hospital, Tokyo
RECRUITING
Cancer Institute Hospital of JFCR, Tokyo
RECRUITING
Kanagawa Cancer Center, Yokohama
ACTIVE_NOT_RECRUITING
Pan-American Center for Oncology Trials, San Juan
ACTIVE_NOT_RECRUITING
Hospital Unversitari, Barcelona
Revolution Medicines, Inc.
INDUSTRY